Request to Join
has invited you to join this group
Dr. Babak J. Orandi, MD PhD MSc, recently completed his general surgery residency at the Johns Hopkins Hospital and will be starting an abdominal transplant fellowship at the University of California San Francisco. His areas of interest include incompatible kidney transplantation, antibody-mediated rejection, and clinical trials in transplantation.
Robert A. Montgomery, MD, DPhil, FACS, is a Professor of Surgery and the Director of the newly formed NYU Langone Transplant Institute. Before coming to NYU he was the inaugural recipient of the Margery K. and Thomas Pozefsky endowed Professorship in Kidney Transplantation. He received his Doctor of Medicine with Honor from the University of Rochester School of Medicine. He received his Doctor of Philosophy from Balliol College, The University of Oxford, England in Molecular Immunology. Montgomery completed his general surgical training, multi-organ transplantation fellowship, and postdoctoral fellowship in Human Molecular Genetics at Johns Hopkins. Dr. Montgomery was part of the team that developed the laparoscopic procedure for live kidney donation, a procedure that has become the standard throughout the world. He and the Hopkins team conceived the idea of the Domino Paired Donation, the Hopkins protocol for desensitization of incompatible kidney transplant patients, and performed the first chain of transplants started by an altruistic donor. He led the team that performed the first 2-way domino paired donation, 3-way paired donation, 3-way domino paired donation, 4-way paired donation, 4-way domino paired donation, 5-way domino paired donation, 6-way domino paired donation, 8-way multi-institutional domino paired donation, and co-led the first 10-way open chain. He is credited in the 2010 Guinness Book of World Records with the most kidney transplants performed in 1 day. He is considered a world expert on kidney transplantation for highly sensitized and ABO incompatible patients. Dr. Montgomery is a co-principal investigator for an NIH/ITN sponsored tolerance clinical trial for simultaneous donor bone marrow and live donor kidney transplantation. He runs multiple investigator initiated clinical trials of novel desensitization therapies. His research interests include mechanisms underlying the immunomodulatory effect of plasmapheresis, stem cell therapy for highly sensitized patients, and gene and cell based therapies in transplantation. He has received important awards and distinctions including a Fulbright Scholarship and a Thomas J. Watson Fellowship and memberships in the Phi Beta Kappa and Alpha Omega Alpha academic honor societies. He has been awarded multiple scholarships from The American College of Surgeons and The American Society of Transplant Surgeons. The National Kidney Foundation of Maryland has recognized his contributions to the field of transplantation with the Champion of Hope Award and National Kidney Registry with the Terasaki Medical Innovation Award.
After receiving his undergraduate and medical degrees from the University of North Carolina, Chapel Hill, Dr. Jordan completed a pediatric internship and residency at the University of California, Los Angeles. He completed three fellowships: one in pediatric nephrology at UCLA, one in experimental pathology in the Department of Immunology at Scripps Clinic and Research Foundation, and the third in dialysis and transplantation at Children's Hospital of Los Angeles. He is board certified in pediatrics, pediatric nephrology and diagnostic laboratory immunology. For more than two decades, Dr. Jordan has performed extensive research into various aspects of immunology and transplantation, funded by dozens of research grants and awards, including two prestigious National Institutes of Health controlled clinical trials in kidney transplantation grants. He has written hundreds of articles and abstracts published in scientific journals, presented findings at medical and scientific organisations and authored about two dozen book chapters. Dr. Jordan's ground-breaking research in transplant immunology led to the development of a drug therapy protocol that significantly reduces the risk of a transplanted kidney being rejected. Dr. Jordan has extensive experience with desensitization for incompatible kidney transplantation and currently has six investigator-initiated clinical trials examining novel therapies for desensitization and treatment of antibody-mediated rejection. Dr. Jordan is the recipient of the National Kidney Foundation “Gift of Life Award” and the Distinguished Alumni Award from the University of North Carolina Chapel Hill. Last year he was honored with the inaugural Cedars-Sinai Prize for Research in Scientific Medicine (PRISM), conceived to recognize outstanding scientific and medical breakthroughs. In addition, Dr. Jordan received the prestigious Cedars-Sinai Pioneer in Medicine Award for his paradigm-shifting discoveries in the fields of immunology and kidney transplants. He and his team pioneered the use of intravenous immunoglobulin to reduce the risk of rejection in difficult cases in which other medications failed. He also created a technique to detect post- transplant lymphoproliferative disorder in its earliest stages.
Dorry Segev, MD, PhD, is the Marjory K. and Thomas Pozefsky Professor of Surgery and Epidemiology and the Associate Vice Chair of Surgery at Johns Hopkins University. Dr. Segev was the first to demonstrate the survival benefit of incompatible kidney transplantation across the United States, and is responsible for the first HIV-to-HIV transplants in the United States. His NIH-funded research includes kidney exchange, desensitization, long-term donor risk, access to transplantation, expanding transplantation including HIV+ donors, geographic disparities, post-transplant outcomes, and the intersection between transplantation and gerontology. With a graduate degree in biostatistics, Dr. Segev focuses on novel statistical and mathematical methods for simulation of medical data, analysis of large healthcare datasets, and outcomes research. Dr. Segev has published over 270 peer-reviewed research articles, including 12 in JAMA, NEJM, and Lancet and over 100 in the American Journal of Transplantation. Reflecting this publication track record, he was recently awarded the American Society of Transplantation's Clinical Science Investigator Award. He is a current councilor of the American Society of Transplant Surgeons and former chair of the American Transplant Congress. His work has directly influenced policy, including two Congressional bills (the Norwood Act for kidney exchange and the HOPE Act for HIV-to-HIV transplants), and is regularly featured in widely read media including TIME magazine, Wall Street Journal, and the New York Times. Dr. Segev is most inspired by his role as a mentor, having mentored over 65 graduate students, residents, and faculty, and is the only general surgeon in the US funded by an NIH/NIDDK Mentoring Grant.